Clinical Trial Update: Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatment [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating topotecan hydrochloride for meningeal cancer in children unresponsive to prior treatment has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leptomeningeal Metastases

Drugs mentioned

• Topotecan (topotecan)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma | Phase 2 | Status: COMPLETED